Abstract: Left ventricular (LV) mass and LV geometry are well-established measures of hypertension chronicity and severity, have a prognostic value on cardiovascular morbidity and mortality, and are related to asymptomatic cerebral small-artery disease (SAD) and largeartery disease (LAD). The aim of the present study was to clarify the different effects of LV mass and LV geometry on underlying SAD compared with its effects on underlying LAD in ischemic stroke patients. Four hundred three ischemic stroke patients underwent echocardiography to determine LV mass index and relative wall thickness. Brain magnetic resonance imaging, angiography, and carotid magnetic resonance angiography were preformed to detect LAD (≥50% stenosis) and SAD (leukoaraiosis, microbleeds, and old lacunar infarction) in the brain. Multivariate analyses showed that the LV mass index was highly associated with underlying SAD but not with underlying LAD. Among the various subtypes of SAD, only cerebral microbleeds were closely related to the LV mass index. Concentric LV hypertrophy was not related to the presence of either SAD or LAD. Subgroup analyses revealed that, among the various subtypes of SAD, only cerebral microbleeds were associated with concentric LV hypertrophy. In conclusion, cerebral microbleeds may imply more advanced target organ damage than underlying LAD and ischemic subtypes of SAD.
Introduction
Echocardiographic left ventricular (LV) mass is a wellestablished measure of hypertension chronicity and severity and an independent predictor of cardiovascular morbidity and mortality [1] [2] [3] [4] [5] . LV mass is associated with incident ischemic stroke [6] and asymptomatic cerebrovascular lesions [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . In patients with LV hypertrophy, ischemic subtypes of cerebral small-artery disease (SAD), such as lacunar infarction [10, 11] or leukoaraiosis [8, 10] , are frequent. Moreover, a close relationship has been reported between LV hypertrophy and cerebral microbleeds in hypertensive stroke patients [9] . In addition, LV mass is associated with large-artery disease (LAD), such as extracranial carotid artery disease [7, [12] [13] [14] [15] [16] [17] [18] .
There have been reports of incremental risk associated with abnormal LV geometry beyond a simple LV mass increase. From LV mass and relative wall thickness, 3 abnormal geometric patterns, i.e., concentric LV hypertrophy, eccentric LV hypertrophy, and concentric LV remodeling, are identified that appear to carry different risks for cardiovascular events [19] : concentric hypertrophy (increase in both LV mass and relative wall thickness) carries the highest risk, followed by eccentric hypertrophy (increased LV mass, normal relative wall thickness) [3, 5] . In subjects with abnormal LV geometry, asymptomatic cerebral lesions are frequent [7] [8] [9] 20] . Furthermore, abnormal LV geometry is associated with extracranial carotid artery disease [7] .
However, it is not known whether LV mass and abnormal LV geometry are more closely associated with SAD or LAD. Because it is known that SAD is more highly associated with hypertension than is LAD [21] , we hypothesized that LV mass and abnormal LV geometry might be more closely related to SAD than LAD. Therefore, our study was performed to clarify the different effects of LV mass and LV geometry on underlying cerebral SAD compared with its effects on underlying LAD in ischemic stroke patients.
Material and Methods

Patient selection
We retrospectively collected the records of ischemic stroke patients with an onset less than 7 days before presentation at Seoul National University Hospital from October 2002 to March 2006. Our study was approved by an independent ethic committee in Seoul National University Hospital (H-1006-134-322) and performed in compliance with the principles of the Declaration of Helsinki (1964) . Four hundred three patients met the following inclusion criteria: 1) the availability of complete clinical and laboratory data, including height, body weight, serum cholesterol concentration, electrocardiography, and transthoracic echocardiography; 2) available medical history concerning hypertension, diabetes, smoking, a history of previous stroke, and antihypertensive and antithrombotic medication; 3) absence of cardiac disease (including congestive heart failure, previous myocardial infarction, and atrial fibrillation) with potential influence on echocardiographic variables [8, 20] ; and 4) artifactfree brain magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) and carotid MRA allowing for the evaluation of SAD and LAD.
Hypertension was considered present if a subject had repeated blood pressure readings above 140/90 mm Hg at intervals of ≥1 week or had a previous history of hypertension or antihypertensive medication. Diabetes was defined as a fasting serum glucose ≥126 mg/dL, a random glucose ≥200 mg/dL, a history of physician-diagnosed diabetes, use of insulin or an oral hypoglycemic agent. An active smoker was defined as a patient who used tobacco within one month of admission. Body mass index was calculated as weight (kg) divided by height (m) squared. Stroke etiology was classified according to the Trial of ORG 10172 in Acute Stroke Treatment criteria [22] .
Echocardiographic studies
Transthoracic echocardiography was performed during a period of convalescence (usually between 7 and 14 days after ictus) using an Acuson 128XP/10c echocardiograph equipped with a V4c multihertz probe (Siemens, Munich, Germany). LV masses were estimated using the formula of Devereux and Reichek (Penn convention) [23] : LV mass (g) = 1.04 × ([LV internal dimension at diastole + interventricular septal thickness + posterior wall thickness] 3 -[LV internal dimension at diastole]
3 ) -13.6. Calculated LV masses were divided by body surface areas to obtain LV mass indices. LV hypertrophy was defined as an LV mass index of >135 g/m 2 for men and >110 g/m 2 for women [9, 24] . Relative wall thickness was calculated using the standard formula [25] : 2 × posterior wall thickness/ LV internal dimension at diastole. Wall thickness was considered to be increased when relative wall thickness was >0.45 [9] . Based on LV morphology, subjects were classified into four groups: concentric LV hypertrophy (LV hypertrophy and increased relative wall thickness), eccentric LV hypertrophy (LV hypertrophy and normal relative wall thickness), concentric LV remodeling (normal LV mass and increased relative wall thickness), and normal geometry (normal LV mass and normal relative wall thickness) [9, 26] .
Transesophageal echocardiography was performed in selected patients when there was a need to assess the right and left atrial cavities or the thoracic aorta.
MRI
Brain MRI (axial T2-weighted spin-echo, fluid-attenuated inversion recovery, and axial T2*-weighted gradient echo sequence) and brain and carotid MRA were obtained as described in our previous studies [9, 21] . MRI and MRA were performed at 1.5T in ≈90% of the patients and at 3T in the other patients.
The presence of underlying LAD (extracranial carotid or intracranial arterial stenosis ≥50%) and of underlying SAD (old lacunar infarction, cerebral microbleeds, or leukoaraiosis) was assessed as described in our previous studies [9, 21, 27] . Cerebral microbleeds were defined as round hypointense lesions of diameter ≤5 mm by gradient echo sequence imaging [9, 21] . Old lacunar infarction was defined as a focal lesion of ≤3 mm and ≤20 mm in diameter with the signal intensity of cerebrospinal fluid [21] . Leukoaraiosis was defined as areas of high signal intensity in the T2-weighted sequences that were located at the periventricular white matter or the centrum semiovale [27, 28] 
Statistical analysis
Differences between the frequency distributions of categorical variables were analyzed using the chi-square test or Fisher's exact test. Differences between the continuous variables were evaluated by the Student's t-test or Kruskal-Wallis test followed by Mann-Whitney tests. A Bonferroni correction for multiple comparisons was applied when necessary. Variables whose p values were <0.15 were selected as potential adjusting variables. Then, 2 separate multivariate logistic regression models were constructed. Model 1 was used to examine the relations of LV mass index and relative wall thickness as continuous independent variables to 5 dichotomous dependent variables (LAD, SAD, and three subtypes of SAD), respectively. Model 2 was used to examine the relations of LV geometry as categorical independent variables to 5 dichotomous dependent variables (LAD, SAD, and three subtypes of SAD), respectively. LV mass index and LV geometry were analyzed separately because of their colinearity. Probabilities of <0.05 were considered significant. All statistical analyses were performed using SPSS 12.0 for Windows (SPSS Inc., Chicago, IL, USA).
Results
Clinical characteristics of the ischemic stroke patients
A total of 403 ischemic stroke patients were included in this study. 
LV mass index and cerebrovascular lesions
First, we investigated the relation of clinical characteristics to LAD and SAD. In univariate analyses, age, and the prevalence of diabetes were significantly higher in patients with LAD than in patients without LAD (Table 2) . Compared with patients without SAD, patients with SAD were more likely to be older, female, hypertensive, and taking antihypertensive medications, and also to have a higher LV mass index and LV relative wall thickness and higher frequency of previous stroke (Table 2) . Second, we examined the associations between clinical characteristics and the various SAD subtypes. In univariate analyses, age, LV mass index, LV relative wall thickness, the prevalence of hypertension, previous stroke, and the prior use of antihypertensive medication were significantly higher in patients with cerebral microbleeds than patients without cerebral microbleeds. The prevalence of smoking was significantly lower in patients with cerebral microbleeds than in the patients without (Table 3) . Age, LV mass index, the prevalence of hypertension and previous stroke, and the prior use of antihypertensive medication were significantly higher in patients with leukoaraiosis than in patients without leukoaraiosis. The frequency of male sex was significantly lower in patients with leukoaraiosis than in patients without leukoaraiosis (Table 4) . LV mass index, the prevalence of hypertension, previous stroke, and the prior use of antihypertensive medication and antithrombotic medication were significantly higher in patients with old lacunar infarction than in patients without old lacunar infarction (Table 5) Table 5 . Clinical characteristics of 403 patients according to the presence of old lacunar infarction. 
Model 1 was used to examine the relations of LV mass index and relative wall thickness as continuous independent variables to a dichotomous dependent variable. Model 2 was used to examine the relation of LV geometry as a categorical independent variable to a dichotomous dependent variable. LV mass index and LV geometry were analyzed separately because of their colinearity. Variables were selected for entry into the multivariate models based on the results of univariate analyses (p<0.15
LV geometry and cerebrovascular lesions
In univariate analyses, the prevalence of SAD was significantly higher in the eccentric LV hypertrophy and concentric LV hypertrophy groups than in the normal geometry group, whereas the prevalence of LAD was similar in the four groups ( Figure 1 ). The prevalence of cerebral microbleeds was higher in the concentric LV hypertrophy group than in the normal geometry and concentric LV remodeling groups. The prevalence of leukoaraiosis was significantly higher in the eccentric LV hypertrophy and concentric hypertrophy groups than in the normal geometry group. The prevalence of old lacunar infarction was similar in the four groups ( Figure 2) .
Next, the LV geometric pattern was dichotomized into concentric LV hypertrophy or other geometric patterns. In univariate analysis, the prevalences of SAD and cerebral microbleeds were higher in patients with concentric LV hypertrophy than in patients without concentric LV hypertrophy (Table 2 and 3) . The multivariate regression analyses demonstrated that concentric LV hypertrophy was not associated with the presence of either SAD or LAD (Table 2 ). Subgroup analyses revealed that among the three subtypes of SAD, only cerebral microbleeds were associated with abnormal LV geometry, especially concentric LV hypertrophy (OR, 1.85; 95% CI, 1.23-3.05) ( Table 3) . 
Combinations of the presence or absence of cerebral microbleeds and ischemic SAD
Patients were divided into 4 groups by the presence or absence of cerebral microbleeds and ischemic SAD as follows: group A, patients without either cerebral microbleeds or ischemic SAD; group B, patients with ischemic SAD but without cerebral microbleeds; group C, patients with cerebral microbleeds but without ischemic SAD; and group D, patients with coexistence of cerebral microbleeds and ischemic SAD. Compared with patients in group A, patients in group B and D were more likely to be older, hypertensive, and taking antihypertensive medications. Compared with patients in group A, patients in group B, C, and D were more likely to have a higher LV mass index. Compared with patients in group A, patients in group D were more likely to have a higher LV relative wall thickness and a higher frequency of previous stroke (Table 6 ).
Discussion
The observation that LV mass may affect the risk of asymptomatic cerebrovascular lesions has precedents in the literature [7] [8] [9] [10] [11] [12] [13] [14] . Several studies have shown associations between asymptomatic ischemic subtypes of SAD and LV mass in hypertensive patients without a stroke history [8, 10, 11] . In addition, in our previous study, which included hypertensive stroke patients, we found that LV mass is correlated with the grade of cerebral microbleeds [9] . Furthermore, LV mass is closely associated with carotid intima-media thickness and the presence of carotid plaque [7, [12] [13] [14] [15] [16] [17] [18] . In our previous study, SAD demonstrated strong associations with hypertension, whereas LAD was associated with diabetes but not with hypertension [21] . LV hypertrophy is likely to occur secondary to hypertension [2] , so we anticipated that SAD, rather than LAD, might be more closely related to LV mass. In agreement with our hypothesis, we found that SAD is associated with LV mass, but that LAD is not. However, contrary to our hypothesis, our regression analyses showed that the ischemic subtypes of SAD (old lacunar infarction and leukoaraiosis) are not associated with LV mass, although the ischemic subtypes of SAD were associated with hypertension. Thus, factors other than the simple presence of hypertension affect the associations between LV mass and cerebral microbleeds.
Although lacunar infarction, leukoaraiosis, and cerebral microbleeds are thought to be signs of underlying microangiopathy, their pathogenic mechanisms may differ slightly [9, 29] . The reason that some individuals with similar risk factors develop leukoaraiosis whereas others develop cerebral microbleeds is unknown. The concept of hypertensive burden measured in the form of LV mass may be an answer to this question. LV mass has been reported to be correlated with the severity of hypertensive retinopathy and renal involvement [1] . Since LV mass is a well established measure of the chronicity and severity of hypertension, cerebral microbleeds may indicate more advanced target organ damage caused by hypertension than may ischemic subtypes of SAD [1, 2] . In accordance with our results, Japanese investigators reported that LV mass is higher in patients with symptomatic hemorrhagic stroke than in those with symptomatic ischemic stroke [30] .
The value of LV geometry in the prediction of cerebrovascular disease has been only minimally investigated [8, 20, 31] . Concentric hypertrophy carries the greatest ischemic stroke risk, followed by eccentric hypertrophy [31] . Concentric remodeling carries a slightly increased stroke risk [31] . Hypertensive patients with concentric LV hypertrophy display more pronounced asymptomatic ischemic cerebral lesions compared with patients with eccentric LV hypertrophy [20] . Concentric LV hypertrophy is reported to be associated with leukoaraiosis in asymptomatic middleaged hypertensive patients [8] . Furthermore, abnormal LV geometry is associated with extracranial carotid artery disease [7] . A stepwise increase in carotid intima-media thickness occurs from the lowest values in subjects with normal LV geometry to intermediate in those with concentric LV remodelling and eccentric LV hypertrophy and to the highest level in subjects with concentric LV hypertrophy [7] . Patients with concentric LV remodelling and concentric LV hypertrophy have a significantly greater relative carotid wall thickness than those with normal LV geometry and eccentric LV hypertrophy [7] . These suggest that LV geometry may contribute to cerebrovascular lesions in ways not necessarily related to LV mass. Our study shows that concentric LV hypertrophy is correlated with the presence of only cerebral microbleeds among three subtypes of SAD. Hypertensive patients with concentric LV hypertrophy have more advanced target organ damage, such as renal and retinal involvement, than those with other LV geometry [1, 32] . This relationship strengthens our belief that cerebral microbleeds imply more advanced target organ damage than does ischemic SAD.
Hypertension was the most consistent risk factor for cerebral microbleeds in previous studies [33] . Age, history of previous stroke, antiplatelet medications, low total serum cholesterol and high HDL-cholesterol concentrations, and LV mass index were also associated with a high prevalence or number of cerebral microbleeds in previous studies [34, 35] . In univariate analyses of our results, age, hypertension, LV mass index, and history of previous stroke were significantly associated with the prevalence of cerebral microbleeds. In multivariate analyses, however, only hypertension and LV mass index remained significant, confirming the fact that hypertension is the most important risk factor for cerebral microbleeds.
Cerebral microbleeds were present in 30.5% of our patients with ischemic stroke. A recent systemic review reported that the prevalence of cerebral microbleeds is 5% in healthy adults, 34% in people with ischemic stroke, and 60% in people with spontaneous intracerebral hemorrhage [33] . Previous distribution analyses of cerebral microbleeds have cast light on the pathogenesis of cerebral microbleeds [9, 36] . Sun et al. have shown that the location of cerebral microbleeds in patients without hypertension was limited to the corticalsubcortical region in 40.3% compared to 20.4% of those with hypertension [36] . Their patients with hypertension had higher frequencies of distribution in the central gray matter (26.1% vs. 17.7%) and the infratentorial region (8.1% vs. 6.5%) than those without hypertension [36] . Previously, we have reported data correlating LV mass index and the presence of microbleeds in precisely the locations seen in patients with hypertensive vasculopathy: the central gray and infratentorial regions [9] . No positive regional relationship was observed in the subcortical white matter [9] . These findings may be related to the epidemiologic data that intracerebral hemorrhages in the basal ganglia or thalamus are generally caused by chronic hypertension and that lobar hemorrhage is caused by various diseases such as cerebral amyloid angiopathy and vascular anomalies [37, 38] . In patients with hypertension, cerebral microbleeds are thought to be due to lipohyalinosis, microatheromas, or Charcot-Bouchard microaneurysms [36] . These predisposing events are primarily found in perforating arteries and deep brain regions including the basal ganglia and thalamus, which, incidentally, are the most frequent locations of cerebral microbleeds in patients with hypertension [36] . The microbleeds burden in the deep gray and infratentorial brain regions may reflect disease chronicity and severity [9] .
There are some limitations to our study. First, we studied underlying SAD and LAD but not acute ischemic stroke mechanisms. We mainly focused on silent lesions in rating cerebral SAD, so we excluded newly developed lacunar infarctions from cerebral SAD. The implication of studying underlying SAD and LAD is obvious since the underlying SAD and LAD are regarded as surrogate markers for future stroke subtypes [39] . Second, LV mass index is only indirect evidence of chronicity and severity of hypertension. We did not collect the data concerning the duration of hypertension in our patients. Third, the imaging modalities varied in our study population; MRI and MRA were performed at 1.5T in ~90% of the patients and at 3T in ~10%. Another limitation is that our results apply only to ischemic stroke patients. We might extrapolate to a population at high risk for developing stroke, but would be cautious about generalizing to a general population.
In conclusion, in ischemic stroke patients, cerebral microbleeds were closely associated with the LV mass index and concentric LV hypertrophy, while underlying LAD and ischemic subtypes of SAD (old lacunar infarction and leukoaraiosis) were not. Cerebral microbleeds may indicate more advanced target organ damage than LAD and ischemic subtypes of SAD.
